In a retrospective study of 3,196 surgery-treated patients with combined hepatocholangiocarcinoma, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma, survival outcomes were analyzed. Despite data limitations, overall survival for combined hepatocholangiocarcinoma was worse than hepatocellular carcinoma but similar to intrahepatic cholangiocarcinoma. Disease-free survival was comparable among the three groups. Predictors of mortality included the cancer subtype, metabolic syndrome, preoperative tumor markers, and satellite nodules, while recurrence was associated with satellite nodules rather than cancer subtype. The study suggests the need for future research on immunophenotypic profiling for better predictive capabilities.
Journal Article by Amory B, Goumard C (…) Brustia R et 31 al. in BMC Surg
Copyright © 2023 Elsevier Inc. All rights reserved.